Previous 10 | Next 10 |
Iterum Therapeutics (ITRM) -41% after FDA identifies deficiencies in sulopenem NDA.Arrowhead Pharmaceuticals (ARWR) -23% after pausing mid-stage AROENaC1001 study in cystic fibrosis.Birks Group (BGI) -13%.Alterity Therapeutics (ATHE) -12%.Kintara Therapeutics (KTRA) -8%.Ci...
These Current & Former Biotech Penny Stocks Have Seen A Strong Year So Far One of the great things about biotech penny stocks is the potential of these companies. There are very few places that offer this kind of early access to potentially life-saving treatments. If you take a ...
Gainers: Ocuphire Pharma (OCUP) +26%, Predictive Oncology (POAI) +21%, Verve Therapeutics (VERV) +21%, HUTCHMED (China) (HCM) +21%, Intellia Therapeutics (NTLA) +19%.Losers: Altimmune (ALT) -36%, electroCore (ECOR) -28%,...
7 Penny Stocks to Watch With Inflation on the Horizon Over the past year and a half, many penny stocks investors have hedged bets against long-term inflation. While fears of inflation can be speculative at times, there are some pretty clear reasons as to why inflation is inevitable righ...
Mario13/E+ via Getty Images Altimmune draws lower price targets on Wall Street after setback Altimmune (ALT) has extended the post-market losses in early hours today with a ~30.3% loss in the pre-market after the company announced an end to its AdCOVID COVID-19 vaccine developm...
Ocuphire Pharma (OCUP) +71% after Phase 2 VEGA-1 trial in presbyopia meets endpoints.Vertex Energy (VTNR) +43% as Clean Harbors to acquire certain assets.Verb Technology Company (VERB) +37%.Bridgeline Digital (BLIN) +29%.AST SpaceMobile (ASTS) +22%.Exela Technologies (XELA) +2...
More than 3,200 pharmaceutical and biotech companies, plus government and academic organizations attended latest BIO Conference Predictive Oncology’s Helomics, TumorGenesis, Soluble Biotech all attended the virtual conference from June 14-18, 2021 Companies leveraged different ...
Collaboration will use TumorGenesis’ expertise in cancer cell culture growth media in combination with Cellevate’s specialty in emerging field of nanofiber matrixes. Cutting-edge technology can help avoid mistakes in $2.6 billion process of bringing new drugs through...
MINNEAPOLIS, June 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) , an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble Biotech Inc. and TumorGenesis Inc. are both expanding their unique services by compl...
Researchers from the Rogel Cancer Center at the University of Michigan have sequenced the RNA of single cells in cancerous and benign kidney tumors. Using that information, they have determined cells from which various subtypes originate and how the tumor micro-environment affects th...
News, Short Squeeze, Breakout and More Instantly...
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
Predictive Oncology Inc. Website:
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) fell 20.2% to $0.03 on volume of 382,247,953 shares BurgerFi International Inc (BFI) rose 97.3% to $0.4205 on volume of 313,737,613 shares NVIDIA Corporation (NVDA) rose 0.7% to $113.06 on volume of 292,060...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 958,117 shares of it...